ImmunityBio, Inc. (FRA:26CA)
Germany · Delayed Price · Currency is EUR 5.20
+0.29 (5.84%)
At close: Jan 30, 2026
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of €5.18 billion as of January 30, 2026. Its market cap has increased by 205.50% in one year.
Market Cap
5.18B
Enterprise Value
5.69B
Revenue
70.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.20
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from 12.47B to 5.18B, a decrease of -58.44%. That is a compound annual growth rate of -16.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 5.18B | 211.95% |
| Dec 31, 2025 | 1.66B | -8.00% |
| Dec 31, 2024 | 1.81B | -40.46% |
| Dec 29, 2023 | 3.03B | 56.14% |
| Dec 30, 2022 | 1.94B | -8.68% |
| Dec 31, 2021 | 2.13B | -82.94% |
| Mar 10, 2021 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |